BR102012029163B8 - Use of roasted coffee oil of the coffee arabica species - Google Patents

Use of roasted coffee oil of the coffee arabica species

Info

Publication number
BR102012029163B8
BR102012029163B8 BR102012029163A BR102012029163A BR102012029163B8 BR 102012029163 B8 BR102012029163 B8 BR 102012029163B8 BR 102012029163 A BR102012029163 A BR 102012029163A BR 102012029163 A BR102012029163 A BR 102012029163A BR 102012029163 B8 BR102012029163 B8 BR 102012029163B8
Authority
BR
Brazil
Prior art keywords
coffee
oil
coffee oil
arabica species
roasted
Prior art date
Application number
BR102012029163A
Other languages
Portuguese (pt)
Other versions
BR102012029163A2 (en
BR102012029163B1 (en
Inventor
Grosselli Lania Bruno
Letícia Cintra Maria
Borlina Maia Nilson
Eduardo Neves Ferreira Velho Paulo
Original Assignee
Inst Agronomico De Campinas
Linax Comerco De Oleos Essenciais Ltda
Univ Estadual Campinas Unicamp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Agronomico De Campinas, Linax Comerco De Oleos Essenciais Ltda, Univ Estadual Campinas Unicamp filed Critical Inst Agronomico De Campinas
Priority to BR102012029163A priority Critical patent/BR102012029163B8/en
Priority to PCT/BR2013/000459 priority patent/WO2014075157A1/en
Publication of BR102012029163A2 publication Critical patent/BR102012029163A2/en
Publication of BR102012029163B1 publication Critical patent/BR102012029163B1/en
Publication of BR102012029163B8 publication Critical patent/BR102012029163B8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição e formulação a base de óleo de café e usos a presente invenção descreve uma composição e sua formulação a base de óleo de café de uso tópico com alta capacidade de cicatrização cutânea. a composição é capaz de manter a área cicatricial com umidade ideal e as áreas periféricas secas e protegidas, além de apresentar uma ação sistêmica, fatores que aceleram o processo cicatricial.coffee oil-based composition and formulation and uses The present invention describes a coffee oil-based composition and formulation for topical use with high skin healing capacity. the composition is able to keep the scar area with ideal humidity and the peripheral areas dry and protected, in addition to presenting a systemic action, factors that accelerate the healing process.

BR102012029163A 2012-11-13 2012-11-13 Use of roasted coffee oil of the coffee arabica species BR102012029163B8 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR102012029163A BR102012029163B8 (en) 2012-11-13 2012-11-13 Use of roasted coffee oil of the coffee arabica species
PCT/BR2013/000459 WO2014075157A1 (en) 2012-11-13 2013-11-01 Composition and formulation based on coffee oil, and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102012029163A BR102012029163B8 (en) 2012-11-13 2012-11-13 Use of roasted coffee oil of the coffee arabica species

Publications (3)

Publication Number Publication Date
BR102012029163A2 BR102012029163A2 (en) 2014-07-15
BR102012029163B1 BR102012029163B1 (en) 2022-02-22
BR102012029163B8 true BR102012029163B8 (en) 2022-03-29

Family

ID=50730415

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102012029163A BR102012029163B8 (en) 2012-11-13 2012-11-13 Use of roasted coffee oil of the coffee arabica species

Country Status (2)

Country Link
BR (1) BR102012029163B8 (en)
WO (1) WO2014075157A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3238307A1 (en) * 2021-11-16 2023-05-25 Unilever Global Ip Limited Skin care composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU82323A1 (en) * 1980-04-02 1981-12-02 Oreal USE OF COFFEE OIL AS A SOLAR FILTERING AGENT, COMPOSITION AND PROTECTION METHOD USING THE SAME
US6716437B1 (en) * 1993-09-13 2004-04-06 E-L Management Corporation Topical composition and method for enhancing lipid barrier synthesis
FR2779645B1 (en) * 1998-06-11 2002-06-07 Sederma Sa COMPOSITIONS FOR COSMETIC OR DERMOPHARMACEUTICAL USE CONTAINING A MIXTURE OF GREEN COFFEE AND SHEA BUTTER EXTRACT
BRPI0602842A8 (en) * 2006-07-20 2017-07-25 Chemyunion Quim Ltda USE OF GREEN COFFEE OIL (COFFEA ARABICA) IN COSMETIC AND PHARMACEUTICAL FORMULATIONS FOR THE MAINTENANCE OF SKIN PROPERTIES
RU2013108970A (en) * 2010-07-30 2014-09-10 Нестек С.А. APPLICATION OF A MIXTURE OF ROASTED AND GREEN COFFEE BEANS FOR THE REGULATION OF SKIN PIGMENTATION
CN103517699B (en) * 2010-07-30 2019-07-12 雀巢产品技术援助有限公司 Roast coffee beans are used to adjust the purposes of cutaneous pigmentation

Also Published As

Publication number Publication date
BR102012029163A2 (en) 2014-07-15
BR102012029163B1 (en) 2022-02-22
WO2014075157A1 (en) 2014-05-22

Similar Documents

Publication Publication Date Title
BR112015022191A2 (en) heteroaryl compounds, their use and composition comprising them
CL2014002757A1 (en) Compounds derived from benzamide to inhibit the activity of abl1, abl2 and bcr-abl1, pharmaceutical composition; and use in the treatment of cancer.
BR112015011830A2 (en) compounds and their methods of use
BR112015008447A2 (en) methods to treat cancer
ECSP14010763A (en) ESTER BORONATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
CL2014001829A1 (en) Compounds derived from indolizine; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer.
BR112014018728A8 (en) PURINONES COMPOUNDS AS KINASE INHIBITORS
CL2013001947A1 (en) Pharmaceutical composition comprising pioglitazone; use of pioglitazone to treat Alzheimer's; composition comprising pioglitazone.
BR112015001847A8 (en) Compositions and treatment for eye diseases and disorders
BR112013013167A8 (en) bromodomain inhibitors and their uses
IL235875A (en) Compositions comprising xylitol and other sugar alcohols for use in treating allergies
CL2014001865A1 (en) Phosphate derived compounds; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer.
BR112013024824A2 (en) Isopentyl esters for use in cosmetic, dermatological or pharmaceutical compositions
BR102013022698B8 (en) Polyglycerol ester, process for its production, its use and cosmetic or pharmaceutical formulation
AR125920A2 (en) COMPOSITIONS COMPRISING VORTIOXETINE AND DONEPEZIL
WO2013102882A3 (en) Cosmetic use of dedifferentiated plant cells
WO2013114394A8 (en) A polyherbal composition for skin care
BR112014019199A8 (en) FREE POLYGLYCOL ETHER SULFOSUCCINATES BASED ON PARTIAL POLYGLYCEROL ESTERS AND THEIR USE
CL2013000866A1 (en) Oxalolate and phosphate crystalline salts of the naloxolpolyethylene glycol conjugate; Preparation method; pharmaceutical composition that includes it; and its use for the treatment of pain.
CL2015000254A1 (en) Vesicles comprising epidermal growth factor (egf); Preparation process; pharmaceutical composition comprising them; and use to treat complex wounds.
BR112015026388A2 (en) wound healing methods and compositions
IN2014KN02914A (en)
WO2013028267A3 (en) Cosmetic use of substituted amino heterocyclic carbamoyl analogs and related compounds
CL2015000537A1 (en) Siarn and its use in methods and compositions for the treatment and / or prevention of eye diseases.
BR112016015997A2 (en) ? PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND 15- HEPE AND METHODS TO TREAT ASTHMA AND PULMONARY DISORDERS WITH THE USE OF THEM?

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/11/2012, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2668 DE 22/02/2022 QUANTO AO INVENTOR.